Is Migraine Infusion Therapy Safe for Frequent Migraines?

Key Takeaways

• Migraine infusion therapy is a well-established treatment option for patients with chronic or refractory migraines, delivered under close medical supervision in a specialty infusion setting.
• The most common infusion therapy for migraine prevention is eptinezumab (Vyepti), a CGRP inhibitor given every three months. Acute infusion protocols may use dihydroergotamine (DHE), magnesium, or medication combinations for severe or prolonged attacks.
• Safety data for migraine infusions is strong, with most patients tolerating treatment well and serious adverse events being rare.
• Ongoing safety depends on thorough pre-treatment screening, careful monitoring during each infusion, and open communication with your neurologist about how you feel between treatments.
• The Denver Arthritis Clinic, with locations in Lowry, Denver, and Lone Tree, CO, delivers advanced migraine infusion therapy through The Infusion Center at Denver Arthritis Clinic. Talk to your neurologist about a referral to The Infusion Center at Denver Arthritis Clinic for migraine infusion therapy.

Physician Referral

What Migraine Infusion Therapy Typically Includes

Migraine infusion therapy is intravenous treatment used either to prevent migraines from happening (preventive infusions) or to break a severe attack that isn't responding to oral medications (acute infusions). It's most often recommended for patients who have chronic migraine (15 or more headache days per month), who haven't responded to standard oral treatments, who overuse acute medications, or who need a bridge between preventive options.

Preventive infusions currently available include:

• Eptinezumab (Vyepti): A CGRP (calcitonin gene-related peptide) inhibitor, given as a 30-minute IV infusion every three months. It targets one of the key proteins involved in triggering migraine attacks. According to the American Migraine Foundation, CGRP inhibitors have become one of the most important advances in migraine care in decades.

Acute infusion protocols include:

• Dihydroergotamine (DHE): Often given as part of a multi-day protocol for status migrainosus (a migraine lasting longer than 72 hours) or for patients breaking a cycle of medication-overuse headache.
• Magnesium sulfate: Sometimes used for acute migraine relief, particularly in patients with menstrual migraines or migraine with aura.
• Combination 'cocktails': These may include an anti-inflammatory (ketorolac), an antiemetic (metoclopramide or ondansetron), a corticosteroid, and IV fluids to treat severe attacks.

Migraine infusion treatment is always tailored to the patient. Your neurologist and the infusion team choose the medication, dose, and schedule based on your migraine pattern, triggers, and prior response to other treatments.

Is Migraine Infusion Therapy Safe? What the Evidence Shows

The safety profile of migraine infusions is generally strong, particularly for CGRP inhibitors like eptinezumab. In the pivotal PROMISE trials, published data on eptinezumab showed that adverse events occurred at similar rates in patients receiving the infusion and those receiving placebo, with the most common events being nasopharyngitis (cold-like symptoms) and mild hypersensitivity reactions.

Older infusion protocols like DHE have decades of safety data. When used with proper screening (ruling out cardiovascular disease, uncontrolled hypertension, and certain medication interactions), most patients tolerate DHE and other acute cocktails well.

Serious adverse events do occur, but they're rare, and the infusion center setting is specifically built to identify and manage them quickly.

Safety Considerations for Ongoing Migraine Treatment

Because CGRP inhibitor infusions are relatively new, and because DHE has known cardiovascular considerations, safety planning matters.

Before Starting Infusion Therapy

Your neurologist will typically review:

• Your full migraine history and prior treatments.
• Any cardiovascular history (heart disease, stroke, uncontrolled hypertension, Raynaud's).
• Pregnancy plans or current pregnancy.
• Medications and supplements that may interact.
• Prior allergic or infusion reactions.

For DHE specifically, patients often need an EKG and cardiovascular clearance before starting.

During Every Infusion

Trained infusion nursing staff monitor:

• Blood pressure, heart rate, and temperature at intervals.
• Any signs of infusion reaction (flushing, hives, chest tightness, changes in breathing).
• Patient comfort and hydration.
• IV site for irritation.

Between Infusions

You'll typically track your headache days, severity, and any side effects in a diary or app. Your neurologist uses this information to decide whether to continue treatment, adjust the plan, or switch approaches.

How Doctors Determine Whether Infusion Therapy Is Appropriate

Not every migraine patient is a candidate for IV infusion therapy for migraines, and that's a good thing. Careful patient selection is part of what makes the treatment safe.

Neurologists generally consider infusion therapy for patients who meet one or more of the following criteria:

Possible Side Effects and How They Are Monitored

Side effects vary depending on the specific medication being infused. Here are the most common ones for the treatments most often used.

Eptinezumab (Vyepti)

• Nasopharyngitis (cold-like symptoms).
• Mild hypersensitivity reactions (flushing, itching, warmth).
• Fatigue.
• Nausea.

DHE

• Nausea and vomiting (typically pre-treated with an antiemetic).
• Muscle cramps.
• Temporary chest tightness or flushing.
• Elevated blood pressure or heart rate.

Cocktail Infusions

• Drowsiness from antiemetics.
• Restlessness (uncommon, from certain antiemetics).
• Mild throat irritation from IV steroids.

Infusion centers monitor for all of these in real time. If a reaction occurs, the infusion is paused or slowed, and appropriate treatment is given. Serious reactions are rare, but the infusion setting is designed to handle them.

When Patients May Benefit From Infusion-Based Migraine Care

Talk to your neurologist about migraine infusion therapy if any of the following apply:

• Your migraines happen more than 8 days per month despite oral preventives.
• You've tried two or more classes of oral preventives without adequate benefit.
• You have side effects from oral medications that are affecting quality of life.
• You've been to the emergency department for a migraine in the last year.
• You're using acute migraine medications more than 10 to 15 days per month.
• You have long attacks (over 24 hours) that don't respond to oral treatment.
• You want a preventive treatment that doesn't require daily dosing.

Schedule Your Migraine Infusion Consultation at The Denver Arthritis Clinic

For patients living with frequent or chronic migraine, infusion therapy offers a genuinely different approach with a strong safety profile and years of clinical experience behind it. The right treatment depends on your migraine pattern, your health history, and your goals, which is why the decision starts with your neurologist and continues with an experienced infusion team.

Talk to your neurologist about a referral to The Infusion Center at Denver Arthritis Clinic for migraine infusion therapy. Our team delivers CGRP infusions and acute migraine protocols in a quiet, comfortable setting at our Lowry, Denver, and Lone Tree, CO locations. Request an appointment or learn more at The Denver Arthritis Clinic.

Frequently Asked Questions